Back to Journals » Hepatic Medicine: Evidence and Research » Call For Papers
Hepatic Medicine: Evidence and Research
The following Article Collection/ Thematic Series is currently open for submissions:
Taylor & Francis’s Gastroenterology and Hepatology journals, together with Guest Advisors Professor Henning Grønbæk, Professor Knut Lundin, and Associate Professor Purnima Bhat, are pleased to invite you to submit your research to the Article Collection “Innovations in Gastroenterology & Hepatology.”
The Collection aims to discuss clinically focused papers highlighting novel successes in precision medicine, from innovations at a molecular level all the way through to diagnostics and treatments in a variety of settings (including low resource).
Possible subtopics include:
- Novel multi-omic molecular / biomarker technologies for diagnosis, treatment response and prognosis in hepatology and gastroenterology
- Repurposing and recycling in low-resource settings
- Novel imaging technologies
- Novel diagnostic and therapeutic endoscopic tools
- Wearable technologies
- Robotics
- Point-of-care diagnostics
- Novel therapeutics
- Precision medicine
- Digital health and artificial Intelligence in hepatology and gastroenterology
- Remote patient care and telehealth / telemedicine
- Novel endoscopy techniques.
- Psychosocial treatment innovations
- New strategies and improvements in healthcare system approaches
The collection spans both Open Access and hybrid journals including: Hepatic Medicine: Evidence and Research, Clinical and Experimental Gastroenterology, Colorectal Cancer, Expert Review of Gastroenterology & Hepatology, Gastrointestinal Oncology: Management and Care, Hepatic Oncology and Scandinavian Journal of Gastroenterology. See here for more information on the journals included and our Guest Advisors.
All Manuscripts submitted to the Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.
The deadline for submissions is 15 January 2027.
Please submit your manuscript on our website, quoting the promo code DC842 to indicate that your submission is for consideration in this Article Collection.
For any questions or discount queries regarding the Collection, please email Rebecca Kearns at [email protected].
Guest advisors
Professor Purnima Bhat, Canberra Hospital and Australian National University
Professor Knut E A Lundin, University of Oslo
Professor Henning Grønbæk
Call For Papers
Editor-in-Chief: Gerond V. Lake-Bakaar, MD
To see where Hepatic Medicine: Evidence and Research is indexed online view the Journal Metrics
What is the advantage to you of publishing in Hepatic Medicine: Evidence and Research?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Although Hepatic Medicine: Evidence and Research receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Hepatic Medicine: Evidence and Research has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
PubMed Central
Hepatic Medicine: Evidence and Research is indexed on PubMed Central (title abbreviation: Hepat Med). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.
Yours sincerely
Dr Gerond V. Lake-Bakaar
Editor-in-Chief
Hepatic Medicine: Evidence and Research
Email: Editor-in-Chief
Updated 11 October 2022